Patents by Inventor Peggy P. Ho

Peggy P. Ho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aquaporin tolerizing vaccines and methods of use thereof
    Patent number: 10098935
    Abstract: The instant disclosure provides aquaporin DNA tolerizing vaccines and methods of using such vaccines for treating individuals having neuromyelitis optica (NMO) and NMO spectrum disorders. Aspects of the methods include administering to the individual, in need thereof, an effective amount of an aquaporin DNA tolerizing vaccine to reduce one or more symptoms of NMO or an NMO spectrum disorder. Compositions and kits for practicing the methods of the disclosure are also provided.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: October 16, 2018
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Lawrence Steinman, Peggy P. Ho
  • TREATMENT OF INFLAMMATORY DEMYELINATING DISEASE WITH AGONISTS OF FARNESOID X RECEPTOR
    Publication number: 20170196893
    Abstract: Provided herein are methods and compositions for treating demyelinating inflammatory diseases by administering to the subject an effective dose on an FXR agonist.
    Type: Application
    Filed: January 6, 2017
    Publication date: July 13, 2017
    Inventors: Lawrence Steinman, Peggy P. Ho
  • AQUAPORIN TOLERIZING VACCINES AND METHODS OF USE THEREOF
    Publication number: 20160317629
    Abstract: The instant disclosure provides aquaporin DNA tolerizing vaccines and methods of using such vaccines for treating individuals having neuromyelitis optica (NMO) and NMO spectrum disorders. Aspects of the methods include administering to the individual, in need thereof, an effective amount of an aquaporin DNA tolerizing vaccine to reduce one or more symptoms of NMO or an NMO spectrum disorder. Compositions and kits for practicing the methods of the disclosure are also provided.
    Type: Application
    Filed: April 21, 2016
    Publication date: November 3, 2016
    Inventors: LAWRENCE STEINMAN, PEGGY P. HO
  • Methods and immune modulatory nucleic acid compositions for preventing and treating disease
    Patent number: 7811813
    Abstract: This invention relates to methods and compositions for treating or preventing disease comprising the administration of immune modulatory nucleic acids having one or more immune modulatory sequences (IMSs). The invention further relates to the means and methods for the identification of the IMSs for preventing or treating disease, more particularly the treatment and prevention of autoimmune or inflammatory diseases. The invention also relates to the treatment or prevention of disease comprising the administration of the immune modulatory nucleic acids alone or in combination with a polynucleotide encoding self-protein(s), -polypeptide(s) or -peptide(s). The present invention also relates to methods and compositions for treating diseases in a subject associated with one or more self-protein(s), -polypeptide(s) or -peptide(s) that are present in the subject and involved in a non-physiological state.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: October 12, 2010
    Assignees: The Board of Trustees of the Leland Stanford Junior University, Bayhill Therapeutics, Inc.
    Inventors: Hideki Garren, Peggy P. Ho, Lawrence Steinman